The Enterprise Value as of June 2026 (TTM) for Lexeo Therapeutics, Inc. Common Stock (LXEO) is 278.74M

According to Lexeo Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 278.74M. This represents a change of -31.42% compared to the average of 406.42M of the last 4 quarters.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Historical Enterprise Value (quarterly & annually)

How has LXEO Enterprise Value performed in the past?

The mean historical Enterprise Value of Lexeo Therapeutics, Inc. Common Stock over the last ten years is 239.87M. The current 278.74M Enterprise Value has changed 11.52% with respect to the historical average. Over the past ten years (40 quarters), LXEO's Enterprise Value was at its highest in in the December 2025 quarter at 703.11M. The Enterprise Value was at its lowest in in the March 2022 quarter at 0.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lexeo Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Average Enterprise Value

How has LXEO Enterprise Value performed in the past?

The current Enterprise Value of Lexeo Therapeutics, Inc. Common Stock (LXEO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lexeo Therapeutics, Inc. Common Stock (LXEO) Enterprise Value vs. Peers

How is LXEO’s Enterprise Value compared to its peers?

Lexeo Therapeutics, Inc. Common Stock’s Enterprise Value is less than Kyverna Therapeutics, Inc. (329.49M), less than Contineum Therapeutics, Inc. Class A Common Stock (430.95M), less than Silence Therapeutics plc (310.47M), greater than Larimar Therapeutics, Inc. (122.82M), less than Capricor Therapeutics, Inc. (1.10B), greater than Mereo BioPharma Group plc (12.46M), greater than Voyager Therapeutics, Inc. (202.73M), less than DBV Technologies S.A. (366.68M), greater than Amarin Corporation plc (189.73M), less than Vanda Pharmaceuticals Inc. (312.03M),

Build a custom stock screener for Lexeo Therapeutics, Inc. Common Stock (LXEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexeo Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexeo Therapeutics, Inc. Common Stock (LXEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexeo Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.